The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma

Endeavor Health100 enrolled

Overview

This is a behavioral randomized controlled trial of adults with uncontrolled persistent asthma that tests if the Propeller Health sensor, mobile application, and dashboard can improve adherence to ICS.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Conditions

Asthma

Interventions

Electronic Medication Monitors on ICS and SABA - Active ModeBEHAVIORAL

The patients in the intervention group will have sensors that are "active", so that these patients receive reminders about when to use their inhalers medications.

Electronic Medication Monitors on ICS and SABA - Silent ModeBEHAVIORAL

The patients in the control group will have sensors that are "silent", so that these patients do not receive reminders about when to use their inhalers medications.

Asthma App Tracking of ICS/SABA Usage - Active ModeBEHAVIORAL

Patients in the intervention group will have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.

Eligibility

Sex: ALLMin age: 25 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Under the care of a staff asthma physician (i.e. pulmonologist or allergist/immunologist) at NorthShore University HealthSystem (NS) * Have an active NorthShore Connect (patient portal) account * Persistent uncontrolled asthma in the past 12 months * Active prescription for daily ICS medication for asthma Exclusion Criteria: * candidate refusal * the presence of other co-morbidities (e.g. severe psychiatric disorder) that could interfere with study participation

Locations (1)

NorthShore University HealthSystem

Evanston, Illinois, United States

Outcomes

Primary Outcomes

Change in Short Acting Bronchodilator Medication use in Group with Propeller Health Platform Digital Technology Turned On vs Group with Propeller Health Platform Digital Technology Turned Off

Use of the Propeller Health Platform in the treatment group in active mode, compared to the attention control group in silent mode, will demonstrate a 20% change in SABA use and/or minimal clinically important difference (three points) change on the ACT and/or change from ACT score ≤ 19 to ≥20, at 3-months. The 20% change in SABA use = 20 point change (e.g. if a participants uses SABA 40% of days over the 2 week run-in period, and they change SABA use to 20% of days during the final 14 days of the active treatment period, that will equal a 20 point change. If SABA use changes from 40% of days over the 2- week run-in period to 32% of days during the final 14 days of the active treatment period, this will not be considered a 20 point change).

Time frame: 3.5 months

Secondary Outcomes

Participant and clinician satisfaction as assessed by brief post-study survey of Propeller Health Platform Digital Technology

Study staff developed a brief survey using open-ended questions (i.e. 20 questions, no scales used, no minimum or maximum scores are applicable) to ask participants and clinicians whether they were satisfied using the Propeller Health Platform Digital Technology. Standardized instruments are not being used.

Time frame: 3.5 months

Inhaled Corticosteroid Medication taking Behavior in the Group using Propeller Health Platform Digital Technology Turned On vs Group using Propeller Health Platform Digital Technology Turned Off

To determine if two Propeller Health Platform Digital Technology arms (i.e. Arm #1= Technology in active "on" mode and Arm #2= Technology in passive "off" mode) demonstrate a change in inhaled corticosteroid medication taking behavior at 3 months.

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.